Earnings Call · Q1 FY2021·2021-05-13

Q1 21EPS -59.38%·Rev n/aQ4 20EPS 0.00%·Rev n/aQ3 20EPS +8.11%·Rev n/aQ2 20EPS +5.48%·Rev n/a⚠ consensus missing

aTYR PHARMA INC ATYR

Ashlee Dunston — Investor Relations

Sanjay Shukla — President and Chief Executive Officer

Leslie Nangle — Vice President of Research

Jill Broadfoot — Chief Financial Officer

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATYR calls or request research access.

More ATYR calls Browse calls Request research access